PKM and cancer: Research has demonstrated that the absence of PKM2 triggers a shift in the TNBC metabolic pathway from glycolysis to fatty acid beta-oxidation (FAO), which continues to supply energy for cancer cell activity (Zhang Y. et al., 2024).